Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription

Articles published in Clin Ther

Retrieve available abstracts of 9 articles:
HTML format
Text format

Single Articles

    March 2018
  1. KITA M, Fox RJ, Gold R, Giovannoni G, et al
    Corrigendum to 'Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (
    Clin Ther. 2018 Mar 7. pii: S0149-2918(18)30055.
    PubMed     Text format    

    December 2017
  2. MOTL RW, Sandroff BM
    Exercise as a Countermeasure to Declining Central Nervous System Function in Multiple Sclerosis.
    Clin Ther. 2017 Dec 26. pii: S0149-2918(17)31106.
    PubMed     Text format     Abstract available

    July 2017
  3. FERNANDEZ O, Giovannoni G, Fox RJ, Gold R, et al
    Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.
    Clin Ther. 2017 Jul 24. pii: S0149-2918(17)30765.
    PubMed     Text format     Abstract available

    February 2017
  4. SOINI E, Joutseno J, Sumelahti ML
    Cost-Utility of First-Line Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis.
    Clin Ther. 2017 Feb 13. pii: S0149-2918(17)30074.
    PubMed     Text format     Abstract available

  5. VAN AMERONGEN G, Kanhai K, Baakman AC, Heuberger J, et al
    Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Delta9-Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis.
    Clin Ther. 2017 Feb 9. pii: S0149-2918(17)30054.
    PubMed     Text format     Abstract available

    February 2016
  6. N'GBO N'GBO IKAZABO R, Mostosi C, Quivron B, Delberghe X, et al
    Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
    Clin Ther. 2016 Feb 4. pii: S0149-2918(16)00023.
    PubMed     Text format     Abstract available

    November 2015
  7. APPLEBEE A, Goodman AD, Mayadev AS, Bethoux F, et al
    Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
    Clin Ther. 2015 Nov 9. pii: S0149-2918(15)01175.
    PubMed     Text format     Abstract available

    October 2015
  8. GIOVANNONI G, Gold R, Fox RJ, Kappos L, et al
    Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
    Clin Ther. 2015 Oct 30. pii: S0149-2918(15)01136.
    PubMed     Text format     Abstract available

    September 2015
    Teriflunomide: A Once-Daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis.
    Clin Ther. 2015 Sep 10. pii: S0149-2918(15)01009.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.